NASDAQ · Financial Statements
Idera Pharmaceuticals, Inc. (IDRA) Financial Statements
$0.43
NASDAQ: IDRA
Overview Financials Dividend Idera Pharmaceuticals, Inc. most recently reported annual revenue of $0, net profit of $-23.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2018 2019 2020 2021 2022 Revenue $1.0M $1.0M $0 $0 $0 Operating Profit $-61.0M $-46.0M $-37.0M $-28.0M $-28.0M Net Profit $-60.0M $-85.0M $-113.0M $98.0M $-23.0M EPS $-38.27 $-33.66 $-56.63 $31.55 $-7.18 Op Margin -9207.9% -3181.4% — — —
Balance Sheet (USD)
Metric 2018 2019 2020 2021 2022 Total Assets $73.0M $47.0M $42.0M $35.0M $101.0M Total Liabilities $9.0M $59.0M $134.0M $5.0M $62.0M Cash $71.0M $40.0M $33.0M $33.0M $12.0M Borrowings $0 $1.0M $1.0M $1.0M $1.0M
Cash Flow (USD)
Metric 2018 2019 2020 2021 2022 Operating Cash Flow $-52.0M $-44.0M $-34.0M $-25.0M $-24.0M Investing Cash Flow $0 $-2.0M $-2.0M $5.0M $5.0M Financing Cash Flow $10.0M $15.0M $29.0M $19.0M $-1.0M Net Cash Flow $-42.0M $-31.0M $-7.0M $-1.0M $-21.0M Free Cash Flow $-52.0M $-45.0M $-34.0M $-25.0M $-24.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.41 FCF Yield — Quick Ratio 0.83 Interest Coverage -136.36 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock